Join EHC 2026 Annual Conference
EHC – European Haemophilia Consortium shared a post on LinkedIn:
”Join us at the EHC 2026 Annual Conference in Istanbul, hosted by Turkish Hemophilia Society.
Although von Willebrand Disease (VWD) is the most common inherited bleeding disorder, it’s still too often overlooked, leading to real challenges in diagnosis, treatment, and long-term care.
Don’t miss this dedicated session exploring the most important topics affecting people living with VWD today:
- Jeroen Eikenboom (Leiden University) provides an update on the latest developments in VWD treatment
- Sebastien L. (Cliniques Universitaires Saint-Luc) examines the relationship between joint health and VWD
- Milica Dimic brings the patient voice to the discussion, sharing her perspective on prophylaxis and the impact treatment decisions can have on daily life
By combining scientific advances with patient experience, this session offers valuable insights into the evolving landscape of VWD care and the importance of a more personalised approach to treatment.
Don’t miss this opportunity to be part of the conversation.
Stay updated with Hemostasis Today.
-
Oct 8, 2026, 16:19Cedric Hermans: Six Webinars Advancing Haemophilia Care And Beyond
-
Oct 8, 2026, 16:09Luana Banu: Every Donation Connects A Human Chain
-
Oct 8, 2026, 15:51Khaled Musallam: A New Era In Thalassemia Care
-
Oct 8, 2026, 15:40Juan J. Ortiz։ Catheter Directed Therapy In Pulmonary Embolism
-
Oct 8, 2026, 15:34Petros Kountouris: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 8, 2026, 15:14Renzo Mancuso: Human Stem Cell Model Reveals Progenitor Fate in Tissue Macrophages
-
Oct 8, 2026, 15:01Yogesh Kumar Jain: The Gift Of Life Through Blood Donation
-
Oct 8, 2026, 14:49Christoph B. Olivier: DOACs Gain Ground in Post-MI Left Ventricular Thrombus Management
-
Oct 8, 2026, 14:46Cesar Garrido: WFH Partners with Tunisia to Expand Hemophilia Care and Treatment Access